Novel Use of Hydromorphone as a Pretreatment Agent: A Double-blind, Randomized, Controlled Study in Adult Korean Surgical Patients

Current Therapeutic Research - Clinical and Experimental

Volumn 72, Issue 1, 2011, Pages 36-48

  Lee, Sang Hyun ^a   Lee, Chul Joong ^a   Kim, Tae Hyeong ^a   Shin, Byung Seop ^a   Lee, Suk Young ^a   Joo, Eun Young ^a   Sim, Woo Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hydromorphone; Induction of anesthesia; Injection pain; Rocuronium; Withdrawal movement

Indexed keywords

FENTANYL CITRATE; HYDROMORPHONE; ROCURONIUM; SEVOFLURANE; SODIUM CHLORIDE; THIOPENTAL;

ADULT; AGED; ANALGESIC ACTIVITY; ANESTHESIA INDUCTION; ARTICLE; ASIAN; COLORECTAL SURGERY; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMICS; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; STOMACH SURGERY; WITHDRAWAL REFLEX;

EID: 79954524098     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2011.02.001     Document Type: Article

References (29)

1. Oh A.Y., Seo K.S., Goo E.K., et al. Prevention of withdrawal movement associated with injection of rocuronium in children: Comparison of remifentanil, alfentanil and fentanyl. Acta Anaesthesiol Scand 2007, 51:1190-1193.
2. Stein C., Schäfer M., Hassan A.H. Peripheral opioid receptors. Ann Med 1995, 27:219-221.
3. Arndt J.O., Klement W. Pain evoked by polymodal stimulation of hand veins in humans. J Physiol 1991, 440:467-478.
4. Blunk J.A., Seifert F., Schmelz M., et al. Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings. Eur J Anaesthesiol 2003, 20:245-253.
5. Kindgen-Milles D., Klement W., Arndt J.O. The nociceptive systems of skin, paravascular tissue and hand veins of humans and their sensitivity to bradykinin. Neurosci Lett 1994, 181:39-42.
6. Hackam D.G., Khan N.A., Hemmelgarn B.R., et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2-therapy. Can J Cardiol 2010, 26:249-258. Canadian Hypertension Education Program.
7. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003, 289:2560-2572. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee.
8. Shevchenko Y., Jocson J.C., McRae V.A., et al. The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents. Anesth Analg 1999, 88:746-748.
9. Cormack R.S., Lehane J. Difficult tracheal intubation in obstetrics. Anaesthesia 1984, 39:1105-1111.
10. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001, 134:663-694. CONSORT GROUP (Consolidated Standards of Reporting Trials).
11. Moher D., Schulz K.F., Altman D. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001, 285:1987-1991. CONSORT Group (Consolidated Standards of Reporting Trials.
12. Murray A., Hagen N.A. Hydromorphone. J Pain Symptom Manage 2005, 29:S57-S66.
13. Rapp S.E., Egan K.J., Ross B.K., et al. A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesth Analg 1996, 82:1043-1048.
14. Sarhill N., Walsh D., Nelson K.A. Hydromorphone: Pharmacology and clinical applications in cancer patients. Support Care Cancer 2001, 9:84-96.
15. Kumar M.G., Lin S. Hydromorphone in the management of cancer-related pain: An update on routes of administration and dosage forms. J Pharm Pharm Sci 2007, 10:504-518.
16. Quigley C. Hydromorphone for acute and chronic pain. Cochrane Database Syst Rev 2002, CD003447.
17. Coda B.A., O'Sullivan B., Donaldson G., et al. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997, 72:333-346.
18. Stein C., Pflüger M., Yassouridis A., et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996, 98:793-799.
19. Mansour A., Hoversten M.T., Taylor L.P., et al. The cloned mu, delta and kappa receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores. Brain Res 1995, 700:89-98.
20. Lamotte C., Pert C.B., Snyder S.H. Opiate receptor binding in primate spinal cord: Distribution and changes after dorsal root section. Brain Res 1976, 112:407-412.
21. Wittmann M., Schaaf T., Peters I., et al. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesth Analg 2008, 107:107-112.
22. Flacke J.W., Bloor B.C., Kripke B.J., et al. Comparison of morphine, meperidine, fentanyl, and sufentanil in balanced anesthesia: A double-blind study. Anesth Analg 1985, 64:897-910.
23. Joo H.S., Salasidis G.C., Kataoka M.T., et al. Comparison of bolus remifentanil versus bolus fentanyl for induction of anesthesia and tracheal intubation in patients with cardiac disease. J Cardiothorac Vasc Anesth 2004, 18:263-268.
24. Lui J.T., Huang S.J., Yang C.Y., et al. Rocuronium-induced generalized spontaneous movements cause pulmonary aspiration. Chang Gung Med J 2002, 25:617-620.
25. Albertin A., Casati A., Deni F., et al. Clinical comparison of either small doses of fentanyl or remifentanil for blunting cardiovascular changes induced by tracheal intubation. Minerva Anestesiol 2000, 66:691-696.
26. Bruder N., Ortega D., Granthil C. Consequences and prevention methods of hemodynamic changes during laryngoscopy and intratracheal intubation [in French]. Ann Fr Anesth Reanim 1992, 11:57-71.
27. Iyer V., Russell W.J. Induction using fentanyl to suppress the intubation response in the cardiac patient: What is the optimal dose?. Anaesth Intensive Care 1988, 16:411-417.
28. Kovac A.L. Controlling the hemodynamic response to laryngoscopy and endotracheal intubation. J Clin Anesth 1996, 8:63-79.
29. Borgeat A., Kwiatkowski D. Spontaneous movements associated with rocuronium: Is pain on injection the cause?. Br J Anaesth 1997, 79:382-383.